Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning.

Autor: Kutzke JL; Department of Pharmacy., Merten JA; Department of Pharmacy., Pawlenty AG; Department of Pharmacy., Barreto EF; Department of Pharmacy., Bartoo GT; Department of Pharmacy., Mara KC; Department of Quantitative Health Sciences., Litzow MR; Department of Hematology, and., Hogan WJ; Department of Hematology, and., Shah MV; Department of Hematology, and., Mangaonkar AA; Department of Hematology, and., Leung N; Department of Nephrology, Mayo Clinic, Rochester, MN., Alkhateeb HB; Department of Hematology, and.

Publikováno v: Blood advances [Blood Adv] 2022 Jul 12; Vol. 6 (13), pp. 3844-3849.

Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma.

Autor: Barreto JN; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Thompson CA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Wieruszewski PM; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Pawlenty AG; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Mara KC; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA., Potter AL; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA., Tosh PK; Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN USA., Limper AH; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2020 Nov; Vol. 61 (11), pp. 2622-2629. Date of Electronic Publication: 2020 Jul 05.